SOX14 hypermethylation as a tumour biomarker in cervical cancer
Open Access
- 7 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 21 (1), 1-10
- https://doi.org/10.1186/s12885-021-08406-2
Abstract
Background: The association between SOX14 and cancer has been reported. The aim of this study was to identify and validate the potential value of SOX14 methylation in the early detection of cervical cancer.Methods: First, we extracted the data for SOX14 methylation and expression within cervical cancer from The Cancer Genome Atlas (TCGA) database and analysed them via UALCAN, Wanderer, MEXPRESS and LinkedOmics. Subsequently, according to the bioinformatics findings, primers and probes were designed for the most significantly differentiated methylation CpG site and synthesized for methylation-specific PCR (MSP) and quantitative methylation-specific PCR (QMSP) to verify SOX14 methylation in both cervical tissuses and liquid-based cell samples. Eventually, the clinical diagnostic efficacy of SOX14 methylation in the normal, cervical intraepithelial neoplasia, and cancer groups was analysed by ROCAUC.Results: Pooled analysis demonstrated that SOX14 methylation levels were significantly increased in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) compared to normal tissues (P < 0.001). Both the verification and validation cohorts indicated that the methylation level and the positive rate of SOX14 gradually increased with increasing severity from normal to cancer samples (P < 0.01). When the cut-off value was set as 128.45, the sensitivity and specificity of SOX14 hypermethylation in the diagnosis of cervical cancer were 94.12 and 86.46%, respectively. When taken as a screening biomarker (>CINII), the sensitivity was 74.42% and the specificity was 81.48%, with a cut-off value of 10.37.Conclusion: SOX14 hypermethylation is associated with cervical cancer and has the potential to be a molecular biomarker for the screening and early diagnosis of cervical cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81601836)
This publication has 45 references indexed in Scilit:
- Epigenetic inactivation of SOX1 promotes cell migration in lung cancerTumor Biology, 2015
- Large-Scale Characterization of DNA Methylation Changes in Human Gastric Carcinomas with and without MetastasisClinical Cancer Research, 2014
- Characterizing DNA methylation alterations from The Cancer Genome AtlasJCI Insight, 2014
- Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central AsiaVaccine, 2013
- SOX1 suppresses cell growth and invasion in cervical cancerGynecologic Oncology, 2013
- Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyAmerican Journal of Obstetrics and Gynecology, 2013
- Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impactEpigenetics, 2010
- Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical CancerThe New England Journal of Medicine, 2007
- Human papillomavirus testing and molecular markers of cervical dysplasia and carcinomaCancer, 2007
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003